-transparent.png){kind=logo}
The present study describes a differential inhibitory effect of captopril and [Sar1 Ala8]angiotensin II (saralasin) on the neurogenic vasoconstriction in pithed normotensive rats. In pithed normotensive rats with intact kidneys captopril more profoundly inhibited the vasopressor response to spinal stimulation than observed for saralasin. Bilateral nephrectomy also diminished the hypertensive response to spinal stimulation. After bilateral nephrectomy, 1 h previously, captopril but not saralasin diminished the hypertensive response to spinal stimulation. After bilateral nephrectomy, 18-24 h previously, captopril did not produce an additional reduction of the vasopressor response to spinal stimulation. In contrast, saralasin significantly potentiated the neurogenic vasoconstriction. The results suggest that both captopril and saralasin diminish the hypertensive response to spinal stimulation by producing dilatation of vascular smooth muscle in pithed normotensive rats. Apart from this common mechanism, a differential effect of captopril and saralasin on the neurogenic vasoconstriction can be observed. In contrast to saralasin, captopril may depress the neurogenic vasoconstriction in pithed normotensive rats by blocking the sympathofacilitatory action induced by subpressor levels of angiotensin II (AII). In pithed normotensive rats, saralasin may mimic the sympathofacilitatory action of subpressor AII.
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
January 1982,
Hypertension (Dallas, Tex. : 1979),
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
January 1982,
Journal of cardiovascular pharmacology,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
November 1989,
The Journal of pharmacy and pharmacology,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
January 1989,
Pharmacology,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
June 1991,
The American journal of physiology,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
November 1992,
Chinese medical journal,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
October 1992,
Journal of cardiovascular pharmacology,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
January 2000,
Naunyn-Schmiedeberg's archives of pharmacology,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
January 2006,
Bulletin of experimental biology and medicine,
A De Jonge, and
B Wilffert, and
M J Thoolen, and
P B Timmermans, and
P A van Zwieten
May 1982,
Clinical science (London, England : 1979),
